Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$3.89
NASDAQLPCN
Open
$3.77
Change
$0.08 (2.10%)
Day's Range
$3.77 - $3.89
52-Week Range
$2.31 - $8.33
Volume
444
Market Cap
$20.7M